Cargando…
From angiotensin-converting enzyme 2 disruption to thromboinflammatory microvascular disease: A paradigm drawn from COVID-19
We concisely review clinical, autopsy, experimental and molecular data of 2019 coronavirus disease (COVID-19). Angiotensin-converting enzyme 2 disruption and thromboinflammatory microangiopathy emerge as distinctive features. Briefly, entry of the virus into microvessels can profoundly disrupt the l...
Autores principales: | Vinci, R., Pedicino, D., Andreotti, F., Russo, G., D'Aiello, A., De Cristofaro, R., Crea, F., Liuzzo, G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654294/ https://www.ncbi.nlm.nih.gov/pubmed/33181158 http://dx.doi.org/10.1016/j.ijcard.2020.11.016 |
Ejemplares similares
-
Platelet hyaluronidase 2 enrichment in acute coronary syndromes: a conceivable role in monocyte-platelet aggregate formation
por: Vinci, Ramona, et al.
Publicado: (2021) -
Meta-Inflammation and New Anti-Diabetic Drugs: A New Chance to Knock Down Residual Cardiovascular Risk
por: d’Aiello, Alessia, et al.
Publicado: (2023) -
Editorial: Artificial intelligence applied to coronary artery diseases: from pathophysiology to precision medicine
por: Vinci, Ramona, et al.
Publicado: (2023) -
Targeting Collagen Pathways as an HFpEF Therapeutic Strategy
por: Bonanni, Alice, et al.
Publicado: (2023) -
Thromboinflammatory challenges in stroke pathophysiology
por: Szepanowski, R.D, et al.
Publicado: (2023)